Clinical trial
A Randomized Clinical Trial to Evaluate the Sedative Effect of the Combination of Remimazolam and Propofol in Drug-induced Sleep Endoscopy
NCT06784479 is registered in ClinicalTrials.gov with Dan Liu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Clinical Trial to Evaluate the Sedative Effect of the Combination of Remimazolam and Propofol in Drug-induced Sleep Endoscopy
- Lead sponsor
- Dan Liu
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- March 1, 2025
- Completion date
- March 1, 2026
- Enrollment
- 174 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive sleep apnea (osa), sedative effect during drug-induced sleep endoscopy